BODI vs GRPN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
BODI
GRPN
Investment Advisor Scores
GRPN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BODI | GRPN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 26.1097 | 153.8462 | BODI |
| PEG Ratio | 0 | 14.657 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -25.0% | 0.0% | GRPN |
| Earnings Growth | 0.0% | 109.2% | GRPN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.3/100 | 52.1/100 | GRPN |
| Profit Margin | 2.2% | -20.8% | BODI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BODI
DistributionPrice near a flattening SMA50 (slope -10.1%) with fading momentum, RSI 44
GRPN
MarkupPrice above SMA50, rising 50-day trend (23.8% over 20 days), RSI 58
Fundamentals Snapshot
| Metric | BODI | GRPN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.7 | 33.2 |
| Trailing P/E | 13.4 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.0% |
| Gross Margin | 0.7% | 0.9% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 0.73 | -2.57 |
| Dividend Yield | — | — |